Opioid chronopharmacology: influence of timing of infusion on fentanyl’s analgesic efficacy in healthy human volunteers by Boom, Merel et al.
© 2010 Boom et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
Journal of Pain Research 2010:3 183–190
 Journal of Pain Research Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
183
 ORiginAL ReseARch
open access to scientific and medical research
Open Access Full Text Article
DOI: 10.2147/JPR.S13616
Opioid chronopharmacology: influence  
of timing of infusion on fentanyl’s analgesic  
efficacy in healthy human volunteers
Merel Boom* 
Joost grefkens* 
eveline van Dorp 
erik Olofsen 
gertjan Lourenssen 
Leon Aarts 
Albert Dahan 
elise sarton
Department of Anesthesiology, Leiden 
University Medical center, Leiden,  
The netherlands; *These authors 
contributed equally to this work
correspondence: Albert Dahan 
Department of Anesthesiology, Leiden 
University Medical center, P5-Q, PO Box 
9600, 2300 Rc Leiden, The netherlands 
Tel +31 71 526 2301 
Fax +31 71 526 2448 
email a.dahan@lumc.nl
Abstract: Chronopharmacology studies the effect of the timing of drug administration on drug 
effect. Here, we measured the influence of 4 timing moments on fentanyl-induced   antinociception 
in healthy volunteers. Eight subjects received 2.1 µg/kg intravenous fentanyl at 2 pm and 2 am, 
with at least 2 weeks between occasions, and 8 others at 8 am and 8 pm. Heat pain   measurements 
using a thermode placed on the skin were taken at regular intervals for 3 hours, and verbal 
  analog scores (VAS) were then obtained. The data were modeled with a sinusoid function using 
the statistical package NONMEM. The study was registered at trialregister.nl under number 
NTR1254. A significant circadian sinusoidal rhythm in the antinociceptive effect of fentanyl 
was observed. Variations were observed for peak analgesic effect, duration of effect, and the 
occurrence of hyperalgesia. A peak in pain relief occurred late in the afternoon (5:30 pm) and a 
trough in the early morning hours (5:30 am). The difference between the peak and trough in pain 
relief corresponds to a difference in VAS of 1.3–2 cm. Only when given at 2 am, did fentanyl 
cause a small but significant period of hyperalgesia following analgesia. No significant changes 
were observed for baseline pain, sedation, or the increase in end-tidal CO2. The   variations in 
fentanyl’s antinociceptive behavior are well explained by a chronopharmacodynamic effect 
originating at the circadian clock in the hypothalamus. This may be a direct effect through 
shared pathways of the circadian and opioid systems or an indirect effect via diurnal variations 
in hormones or endogenous opioid peptides that rhythmically change the pain response and/or 
analgesic response to fentanyl.
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Introduction
Chronopharmacology studies the effect of the timing of drug administration (in terms 
of the hour in a 24 hour period, the day in a 1-month or 1-year period, or the year in a 
lifetime) on the drug’s pharmacokinetics and/or pharmacodynamics.1,2 When applied 
to the 24-hour circadian rhythm, it is known that numerous drugs exhibit a differential 
response depending on the time of administration. This also applies to drugs used in 
anesthesia, such as local anesthetics, barbiturates, muscle relaxants, and opioids.1,2 
For opioids, circadian effects have been observed for drug disposition (eg, meperidine 
and morphine) and therapeutic sensitivity (eg, tramadol and codeine).2,3 However, 
the number of studies on opioid pharmacology is restricted; hence, knowledge on 
the influence of the circadian rhythm on opioid analgesic efficacy remains poor.2 
Evidently, further understanding and application of a chronotherapeutic approach to 
opioid treatment of acute and chronic pain would increase opioid efficacy and possibly 
improve the efficacy–safety balance. Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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To scrutinize the hypothesis that opioids display a diurnal 
antinociceptive effect, we performed a study on the influence 
of 4 distinct timing moments on fentanyl-induced analgesia 
in healthy volunteers. The analgesic effect of intravenous 
fentanyl, administered at 8 am, 2 pm, 8 pm, or 2 am, was 
examined using an experimental heat pain model.
Methods
Following approval of the protocol by the Leiden   University 
Medical Center Human Ethics Committee, 16 healthy volun-
teers (12 women and 4 men; aged 18–30 years; body mass 
index [BMI] ,28 kg/m2) were enrolled in the study. 
The study protocol complied with the Helsinki declaration. 
The study was registered at trialregister.nl (No. NTR1254). 
Written and oral informed consent were obtained prior to 
the inclusion in the study. Exclusion criteria include age 
,18 years, BMI .30 kg/m2, presence of underlying dis-
ease, history of drug allergy, history of psychiatric disease, 
history of illicit substance abuse. All female subjects were 
taking oral contraceptives. The subjects were instructed not 
to eat or drink for at least 6 hours before the study.
Heat pain was induced using the TSA-II Neurosensory 
Analyzer (Medoc Ltd, Ramat Yishai, Israel). Using a 3-cm2 
probe, the skin on the volar side of the left or right forearm 
was stimulated with a gradually increasing stimulus (0.5°C/
sec; baseline temperature 32°C). The volar side of the arm 
was divided into 6 zones and marked as previously described.4 
The thermode was moved from zone to zone between stimuli 
to avoid sensitization to heat stimulus. Following heat stimu-
lation, the subjects scored their verbal analog scores (VAS) 
in pain intensity on a 10-cm long scorecard. The thermode 
peak temperature depended on an initial trial phase in which 
the subject rated the pain to 3 peak temperatures: 46°C, 
48°C, and 49°C. The lowest stimulus causing a VAS .5 cm 
was used in the remainder of the study. The test data were 
discarded. Then, baseline values (ie, predrug VAS) were 
obtained. Baseline values were obtained on each of the 2 
experimental sessions.
The subjects were randomly divided into 2 experimental 
groups. The first group received fentanyl at 2 pm and 2 am 
and the second group at 8 am and 8 pm. The experimental 
days were separated by a 2-week washout period. We stud-
ied 2 distinct groups to reduce the number of occasions at 
which the healthy volunteers were exposed to potent opioid. 
At the appropriate time, 2.1 µg/kg intravenous fentanyl was 
administrated intravenously over 90 seconds. Subsequently, 
heat pain measurements were taken every 10 minutes for 
3 hours (first pain test at 10 minutes after the start of the 
fentanyl infusion). Additionally, at each testing interval, a 
verbal rating score of sedation using a scale ranging from 
0 to10 (from 0 = fully alert to 10 = severely sedated and 
sleepy) and end-tidal CO2 measurements were obtained via 
a face mask connected to a gas monitor (Multicap, Datex, 
Helsinki, Finland). Arterial hemoglobin oxygen saturation 
was measured via a finger probe (SpO2) with a pulse   oximeter 
(Masimo, Irvine, California). The study was powered to 
observe a 1-cm difference in VAS of a 10-cm scale ranging 
from 0 ( = no pain) to 10 (= most intense pain imaginable) 
between 2 study groups (power = 90%; α = 0.05).
A linear mixed model was used to compare the baseline 
parameter values (thermode temperature to reach a VAS .5, 
sedation score, and end-tidal CO2) using SPSS 16.0 software 
(SPSS, Chicago, Illinois). P values , 0.05 were considered 
significant. To quantify the effect of fentanyl on pain relief, 
we initially assessed the effect relative to baseline (ie, 
∆VAS, by subtraction of baseline VAS at each time point), 
and subsequently, we calculated the area between the VAS 
data points and the zero line (area between the effect-time 
curves, AECs). Consequently, the more negative the AEC 
the more analgesic the response. We present the AEC data 
as mean change in VAS over time (ie, AEC/180 minutes; 
unit = cm). Then, to get an indication of the presence of a 
circadian effect on fentanyl analgesia, the data were modeled 
using a sinusoid function:
  AEC(t) = offset + A sin(2πft + ϕ)
where, the A = amplitude, f = frequency (occurrence of the 
sinus per 24 hour), and ϕ = a phase shift. To obtain the 95% 
confidence interval of the sinusoid, a bootstrap analysis 
was performed using 1,000 reiterations with replacement. 
Data analysis was performed using the statistical package 
NONMEM version VI (ICON Development Solutions, 
Ellicott City, Maryland).5 For sedation and end-tidal CO2, the 
area under the effect-time curves were calculated (without 
subtraction of baseline values) and compared using a linear 
mixed model.
Results
No differences in baseline parameters were observed within 
group or between groups (Table 1). In each group, there were 
6 women and 2 men. None of the subjects were nightshift 
workers, had passed international times zones in the 3 months 
before the study, or reported sleep disturbances. The subjects 
completed the study without major side effects. Incidental 
occurrences of low SpO2 (,95%) were treated by prompting 
the subject to take a deep breath.Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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All injections were performed at the planned time of 
day ± 4.3 minutes (maximal range; no significant difference 
between groups). After injection, all volunteers reached maxi-
mal analgesia within 20 minutes and returned to within 10% 
of their baseline pain sensitivity levels by the end of the experi-
ment. The influence of the time of infusion on ∆VAS is shown 
in Figures 1 and 2. Time-related variations are observed for 
peak analgesic effect (with the least effect at 2 am), duration of 
effect (with the shortest duration at 8 am), and the occurrence 
of a small hyperalgesic response (most pronounced at 2 am). 
Individual AEC values (all divided over 180 minutes, giving 
the mean change in VAS over 180 minutes) vs study time are 
given in Figure 3 together with the data fit (± 95% confidence 
interval). A significant sinus wave was present in the data 
(the wave was significantly different from a linear response line, 
P , 0.01). The parameter values are offset = −0.63 ± 0.25 cm, 
A = 0.65 ± 0.20 cm, and ϕ = 27 ± 21 degrees (all parameters 
P , 0.01, values are typical value ± SE). The negative value 
of the offset indicates that on average at all times, an analge-
sic response occurred. An amplitude of 0.65 means that the 
  average VAS varied by 1.3 cm over time (recalculation for just 
the first 90 minutes of the experiment would yield a variation 
in VAS of 2 cm; note that these variations are model predic-
tions). The value of ϕ of 27 degrees indicates that at midnight 
Table 1 Baseline parameter values and 3-hour area under the time-effect curve for end-tidal cO2 and sedation
8 am–8 pm 2 am–2 pm
Baseline values
  Temperature of thermode (°c) 48.5 ± 0.8–48.6 ± 0.8 48.2 ± 1.5–48.7 ± 1.4
  Baseline pain VAs (cm) 7.8 ± 0.4–7.7 ± 0.4 6.6 ± 0.9–6.8 ± 0.7
  Baseline cO2 (volume %) 4.7 ± 0.6–5.1 ± 0.5 4.7 ± 0.8–4.6 ± 0.5
  Baseline sedation nRs (cm) 3.1 ± 0.7–1.9 ± 0.8 2.0 ± 0.4–1.0 ± 0.3
3-h AUecs
  cO2 (time × volume %) 47 ± 22–41 ± 21 33 ± 40–48 ± 14
  sedation (min*cm) 125 ± 131–198 ± 153 188 ± 110–272 ± 190
Notes: No significant differences in parameter values were obtained among the study times (ANOVA: P . 0.05).
Abbreviations: VAs, visual analog score; nRs, numerical rating score; AUec, area under the time-effect curve; AnOVA, analysis of variance.
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Figure 1 effect of fentanyl on heat pain scores in 2 groups of subjects. A and C, One group received intravenous 2.1 µg/kg fentanyl at 8 am and 8 pm; B and D, the other 
group at 2 pm and 2 am. Values are mean ± sD. Baseline values (ie, predrug values) are given at time t = 0. 
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Figure 2 Mean pain scores relative to baseline (ie, ∆VAs with baseline = 0 at time t = 0) after injection of 2.1 µg/kg fentanyl observed at 2 am, 8 am, 2 pm, and 8 pm.
Abbreviation: VAs, visual analog score.
(0 hour in Figure 3), the sinus was shifted by 27 degrees. 
The frequency value f was fixed to 1 as we assumed that the 
sinus occurred once every 24 hour. Fentanyl was most analgesic 
in the late afternoon and early evening hours (between 2 pm 
and 8 pm; minimum of the sinus occurred at 5 am), whereas it 
was least analgesic in the early morning hours (from 2 am to 
8 am; maximum of the sinus occurred at 3 pm).
Side effects showed much less of a variation over time 
than analgesia with no differences among observations 
within and between groups (analysis of variance [ANOVA]: 
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Figure 3 Data fit of analgesic effect from 2.1 µg/kg intravenous fentanyl vs time of day at which the drug was injected. Analgesic effect is defined as the mean change in VAS 
over the 180-minutes study period. Each circle represents the analgesic effect of one subject. The fit is a sinusoidal curve (thick continuous line) ±95% confidence interval (thin 
continuous lines). The broken line denotes a separation between mean analgesic responses (data below the broken line) and hyperalgesic responses (above the broken line). 
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P . 0.05; Table 1). A significant sinus could not be 
  demonstrated for end-tidal pCO2 or sedation.
Discussion
We observed a circadian sinusoidal rhythm in the analgesic 
effect of fentanyl. Variations were observed for peak analge-
sic effect, duration of effect, and the occurrence of hyperal-
gesia. When using AEC as end point, we observed a peak in 
pain relief late in the afternoon (5:30 pm) and a trough in the 
early morning hours (5:30 am). The difference between the 
peak and trough in pain relief corresponds to a difference in 
VAS of 1.3–2 cm. This indicates that the magnitude of the 
diurnal variation of fentanyl analgesia is significant, albeit 
relatively small with increased sensitivity to fentanyl in the 
late afternoon and early evening hours (1–11 pm).
Opioid effect on the circadian rhythm
Our study did not specifically examine the suprachiasmatic 
nucleus (SCN) or endogenous opioid pathways. Taken into 
account the current knowledge on the interaction of the 
circadian clock and opioid pathways, an interaction of the 
2 systems seems possible, although at present this remains 
speculative. In mammals, the SCN in the hypothalamus 
is the site that controls circadian behavioral rhythmic-
ity (ie, the master clock).6,7 The SCN is synchronized by 
external stimuli of which the light or dark cycle is the most 
important (the retina is directly linked to the SCN via the 
  retinohypothalamic tract). Other synchronizers include 
locomotor activity, drugs (eg, benzodiazepines, opioids, and 
serotonin agonists), and social interaction. The SCN controls 
many cyclic events in the mammalian body including the 
synthesis and release of hormones, such as melatonin and 
cortisol, and body temperature. The generation of rhythmicity 
in the SCN is genetically determined and based on feedback 
loop that involves several genes, including Per1, Per2, and 
Clock.6,7 The SCN and its afferent and efferent pathways 
contain various neurotransmitters including neuropeptide Y, 
γ-amino butyric acid, and enkephalins. The role of enkepha-
lins in the circadian system has received increasing attention 
as δ-opioid   receptors were identified in the hamster SCN, 
and the µ-opioid receptor agonist fentanyl induces a phase 
shift in the circadian rhythm of hamsters independent of 
any behavioral effects of the opioid.8,9 We showed previously 
that fentanyl modifies the circadian pacemaker possibly via 
direct effects on SCN electrical activity and regulation of 
Per genes.8 This suggests that pathways regulating the cir-
cadian clock intersect directly or indirectly with pathways 
that express opioid receptors. Then, our current study, in 
which a diurnal variation in fentanyl’s analgesic behavior is 
observed (ie, an effect opposite to fentanyl’s influence on the 
clock), could be interpreted as showing involvement of the 
opioid system in the circadian rhythm. Alternatively, other 
studies indicate that circadian rhythms entrained to drugs of 
abuse and rewarding stimuli (eg, methamphetamine-sensitive 
circadian oscillator, daily rhythm of food-anticipatory behav-
ioral activity, and food or chocolate anticipatory timing sys-
tems) are mediated independently of the photic entrainment 
system,10–12 suggesting that also for opioids, entrainment may 
occur distinct from the known circadian clock. Evidently, 
further studies are needed to elucidate the interaction between 
the known circadian clock and opioid pathways.
We refrained from measuring plasma fentanyl concentra-
tions in our observational study. We discussed that frequent 
blood sampling could interfere with the subject rating of 
heat pain possibly causing stress-induced analgesia that 
encompasses strong circadian variations.13 Consequently, the 
variation in fentanyl’s effect may be due to a true increase 
in the opioid’s antinociceptive efficacy (a pharmacodynamic 
effect), as suggested above, but we cannot exclude a diurnal 
variation in fentanyl’s pharmacokinetics. An increase in 
plasma fentanyl concentrations in the late afternoon and 
early evening may well explain our findings. Variations in 
plasma morphine concentrations following oral administra-
tion in patients with cancer pain have been observed due 
to variations in absorption and/or changes in the volume of 
distribution over a 24-hour period.14 Similarly, intramuscular 
meperidine injections in patients with sickle cell anemia were 
associated with circadian changes in drug disposition and 
elimination over the day.2 In contrast, oral codeine and tra-
madol given to healthy volunteers in the morning or evening 
did not show any differences in pharmacokinetics.3 Similarly, 
and of importance to our study, in 2 separate studies, in 
  volunteers receiving intravenous fentanyl, the plasma fen-
tanyl concentration–time profiles were independent of the 
time of infusion.15 This then suggests that our findings are 
related to a circadian effect on fentanyl’s pharmacodynamics 
and not to its pharmacokinetics.
circadian variations in the pain response
Several animal studies showed that the response to noxious 
stimuli is not constant over a 24-hour period.1,2,13,16 The results 
of human experimental and clinical studies are less clear with 
some studies finding no difference in pain over time, whereas 
others found more pain in the morning or evening.1,2,17–19 
Experimental pain studies indicate that variations in pain 
sensitivity depend on the tissue tested and the nociceptive  Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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assay employed.1,2,17–19 Using a similar thermode as we did, 
Strian et al18 did observe a variation in pain threshold values 
to warm and cold stimuli, but these variations were small and 
had no consistent pattern among subjects. Our study was not 
designed or powered to study variations in pain sensitivity 
and, as expected, we did not observe significant differences 
in temperature to induce VAS . 5 cm. However, at this point, 
we cannot exclude some effect of variations in pain sensitivity 
on the antinociceptive responses that we observed with less 
pain reporting between 1 pm and 11 pm (and hence a greater 
analgesic response at these times). Indeed, skin sensitivity 
to heat is minimal at 6 pm and maximal at 6 am, and painful 
stimulation of the nasal mucosa with CO2 is also increased 
during evening test sessions.17,20 Further studies are needed 
to investigate the complex interaction between variations in 
pain sensitivity and opioid treatment. An important question 
in this respect is, eg, whether the pain and analgesic rhythms 
display antagonistic or synergistic interactions.
Mechanisms of opioid circadian rhythm
The mechanism through which the circadian rhythm affects 
opioid analgesic efficacy remains unknown. Variations in 
hormones (eg, cortisol, melatonin) and endogenous opioid 
peptides (metaenkephalin and β-endorphins) could play an 
important role in interacting with the nociceptive pathways 
and opioid system.21–23 For example, the analgesic effect 
of melatonin is more pronounced at night.24 An interesting 
observation in mice is that µ-opioid receptor expression 
displays a 24 hour rhythm.25 Downregulation of the brain 
µ-opioid receptor was associated with a decrease in mor-
phine analgesia. Extrapolation of these animal data to ours in 
humans then suggests that during the late evening, morning, 
and early afternoon, human µ-opioid receptors are downregu-
lated via a direct or indirect (eg, hormonal) influence of the 
SCN. Our finding of enhanced analgesic fentanyl efficacy 
from 1 pm to 11 pm is in agreement with other human studies 
showing similar patterns of opioid effect. Nonlethal opioid 
overdose (ie, increased opioid sensitivity causing respiratory 
depression) shows a significant peak in the afternoon and 
early evening, an effect that was independent of the opioid 
plasma concentrations.26 Oral codeine and tramadol display 
greater analgesic sensitivity when administered in the early 
evening.3
hyperalgesia
A somewhat surprising observation in our study was the 
occurrence of a moderate hyperalgesic response (pain sen-
sitivity greater than baseline) following analgesia in subjects 
receiving fentanyl at 2 am (Figure 1). This phenomenon 
was outspoken in 5 subjects tested at 2 am and occurred on 
11 occasions in the whole study (Figure 3). Hyperalgesia 
in response to opioids has been observed in various species, 
including humans. Recent data indicate that opioid-induced 
hyperalgesia is not related to activation of opioid receptors 
but possibly due to activation of N-methyl-d-aspartic acid 
receptors within pain pathways.27,28 Animal studies showed 
that hyperalgesia induced by opioid-receptor blockade by 
naloxone (ie, a nonopioid receptor phenomenon) follows 
a diurnal rhythm.29 This then suggests that our results may 
have been influenced by 3 separate rhythms: an inherent pain 
rhythm, a fentanyl analgesic, and antianalgesic rhythm.
critique of methods
It may be discussed that the observed rhythm is partly related 
to the use of 2 distinct subject groups, one of which was 
studied at 8 am and 8 pm, the other at 2 pm and 2 am. This 
could, eg, occur when the 2 groups would differ in their 
AECs without a within-group difference between measure-
ment points (eg, [AEC [group 1] at 2 pm = 2 am] . [AEC 
[group 2] at 8 am = 8 pm]). However, this was not the case 
(Figures 1 and 2). In both groups, the data collected in the 
morning hours (2 am or 8 am) displayed a peak effect and 
AEC of lesser magnitude than the data collected in the after-
noon or early evening hours (2 pm or 8 pm). This suggests 
that the observed rhythm was inherently present in the 2 study 
groups and not related to the design of the study.
We modeled the data with a symmetrical sinusoid func-
tion. This function was significantly better than a linear 
function. We did assess also nonsymmetrical sinusoid 
functions by allowing the 4 parts of the sinusoid to vary 
independently in amplitude (with factor FAC). However, 
no significant improvements in minimum objective function 
were observed in comparison to FAC value of 1. Furthermore, 
assessing the residuals of the symmetrical sinusoid func-
tions showed the absence of any bias (means residuals per 
test period not different from zero). This indicates that the 
sinusoid chosen adequately described the data.
We subtracted the baseline pain score from the VAS–time 
data to allow objective assessment of the change in VAS over 
time (AEC). This was possible in our data set as we observed 
little variation in the baseline VAS (predrug) score. We 
cannot exclude, however, that some error in baseline values 
may erroneously propagate to the estimates of the model 
parameters. However, in our analysis, the error only propa-
gates to the interindividual variability of the model parameter 
offset. We tested the variance in offset and observed that Journal of Pain Research 2010:3 submit your manuscript | www.dovepress.com
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it was not different from zero, suggesting that subtraction 
of baseline pain scores did not affect our study outcome. 
In some studies, the analysis of circadian effects is sensitive 
to “edge effects” or the moment in time defined as the start 
of day or start of analysis (this is often related to the use of 
a smoothing function).30 We chose midnight as starting point 
of our analysis. Our NONMEM analysis of the data with a 
nonsmoothed sinusoid does not have any edge effects.
Recent studies on chronopharmacology of labor anal-
gesia with intrathecal bupivacaine indicate that one has to 
be careful with the interpretation of rhythmic patterns in 
the duration of analgesia.30 This concerns patient studies in 
which daily routines (external rhythms such as nursing and 
anesthesia provider shifts) produce artifacts (suggesting a 
biological rhythm in intrathecal analgesia duration) that have 
little to do with biological rhythms.30 We were aware of these 
pitfalls and designed our study to prevent influences from 
external rhythms. However, despite our efforts, we cannot 
exclude some albeit small effect from external sources on 
our study outcome.
We used intravenous fentanyl, which is used in the 
treatment of acute pain and in the perioperative setting to 
prevent pain and cardiovascular stimulation. In chronic 
pain treatment, the drug is commonly used orally or via a 
dermal path. Because it seems improbable that the mode of 
administration affects the chronopharmacological behavior 
of fentanyl (as discussed above, the effects are pharmaco-
dynamic in nature and not pharmacokinetic), we assume 
that the results that we obtained also apply to the chronic 
pain setting.
We tested both male and female subjects. There is now 
ample evidence that opioids show greater analgesic effect in 
women compared to men.31 The data obtained in the 4 male 
subjects fell well within the female data range, suggesting the 
absence of a sex effect in our data set. However, our study 
was neither designed nor powered to unearth sex differences, 
and therefore, the existence of possible sex differences in 
the chronopharmacological behavior of fentanyl requires 
further study.
Conclusion
We observed a circadian rhythm in the analgesic effect of 
fentanyl in human volunteers using an experimental heat pain 
model. Our data indicate an increase in analgesic efficacy 
in the late afternoon and early evening hours. We argue that 
the most probable cause for our findings is chronopharma-
codynamic effect regulated by the circadian clock in the 
hypothalamus. This may be a direct effect through shared 
pathways of the circadian system and the opioid system 
or an indirect effect via diurnal variations in hormones or 
endogenous opioid peptides that rhythmically change the 
pain response and/or analgesic response to fentanyl.
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